The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis

The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis

Abstract Background Previous studies have demonstrated the benefits of thymosin alpha-1 (Tα1) in anti-virus, immunological enhancement and anti-inflammation. However, it is controversial about the efficacy and safety of entecavir (ETV) plus Tα1 combination therapy versus ETV monotherapy in cirrhotic...

Full description

Bibliographic Details
Main Authors: Dan Peng, Hai-Yan Xing, Chen Li, Xian-Feng Wang, Min Hou, Bin Li, Jian-Hong Chen
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Gastroenterology
Subjects:
HBV
Cirrhosis
Entecavir
Thymosin alpha-1
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12876-020-01477-8

Internet

http://link.springer.com/article/10.1186/s12876-020-01477-8

Similar Items